{"id":"NCT02432105","sponsor":"Alcon Research","briefTitle":"Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT)","officialTitle":"Safety and Efficacy of EXE844 Otic Suspension in the Treatment of Otitis Media at Time of Tympanostomy Tube Insertion","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-06-25","primaryCompletion":"2016-06-15","completion":"2016-06-15","firstPosted":"2015-05-01","resultsPosted":"2017-07-12","lastUpdate":"2018-07-02"},"enrollment":470,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Otitis Media With Effusion in Children","Otitis Media Recurrent"],"interventions":[{"type":"DRUG","name":"EXE844 Sterile Otic Suspension, 0.3%","otherNames":[]},{"type":"PROCEDURE","name":"Tympanostomy Tube Insertion","otherNames":[]}],"arms":[{"label":"EXE844 for 7 Days + Tubes","type":"EXPERIMENTAL"},{"label":"EXE844 for 3 Days + Tubes","type":"EXPERIMENTAL"},{"label":"Tubes Only","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate EXE844 plus tympanostomy tubes compared to tympanostomy tubes only based on sustained clinical cure at end-of-therapy (EOT).","primaryOutcome":{"measure":"Percentage of Subjects With Sustained Clinical Cure at Day 8","timeFrame":"Day 8","effectByArm":[{"arm":"EXE844 7 Days","deltaMin":76.2,"sd":null},{"arm":"EXE844 3 Days","deltaMin":71.8,"sd":null},{"arm":"Tubes Only","deltaMin":56.8,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":470},"commonTop":["Pyrexia","Otorrhoea","Upper respiratory tract infection","Ear pain","Vomiting"]}}